FindTrial
Sign In

Adjuvant chemotherapy in stage Ia NSCLC with high risk recurrence

Adjuvant chemotherapy in stage Ia NSCLC with high risk recurrence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16009649
Enrollment
Unknown
Registered
2016-10-27
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Chemotherapy group:Chemotherapy
Observe group:Without chemotherapy

Sponsors

Shanghai Pulmonary Hosptial, Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patients with non small cell lung cancer; 2. The patients aged 18 years to 70 years old; 3. The non-small cell lung cancer patients in Ia of TNM staging; 4. The non-small cell lung cancer patients with 0-1 in PS scores; 5. With stage Ia non-small cell lung cancer with high risk recurrence.

Exclusion criteria

Exclusion criteria: 1. The patients with serious heart, liver, kidney disease; 2. The non-small cell lung cancer patients cannot tolerate chemotherapy.

Design outcomes

Primary

MeasureTime frame
DFS;—

Secondary

MeasureTime frame
OS;QOL;—

Countries

China

Contacts

Public ContactGening Jiang

Shanghai Pulmonary Hosptial, Tongji University School of Medicine

jgnwp@aliyun.com+86 13003172161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026